PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Computational Biology and Molecular Simulations Laboratory, Department of Biophysics, School of Medicine, Bahcesehir University, 34734, Istanbul, Turkey.\', \'Neuroscience Program, Graduate School of Health Sciences, Bahçeşehir University, 34353, Istanbul, Turkey.\', \'Virtual Drug Screening and Development Laboratory, School of Medicine, Bahcesehir University, 34734, Istanbul, Turkey.\', \'Head of Department of Basic Medical Sciences, Head of Department of Biophysics, School of Medicine, Bahcesehir University, Durdagi Research Group (DRG), 34734, Istanbul, Turkey.\', \'Department of Medical Biology, School of Medicine, Bahcesehir University, 34734, Istanbul, Turkey.\', \'Department of Molecular Biology and Genetics, Bogazici University, 34470, Istanbul, Turkey.\', \'Head of Department of Medical Biology.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/minf.202100062
?:hasPublicationType
?:journal
  • Molecular informatics
is ?:pmid of
?:pmid
?:pmid
  • 34529322
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.573
?:rankingScore_hIndex
  • 59
is ?:relation_isRelatedTo_publication of
?:title
  • Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of SARS-CoV-2: A Combined in silico and in vitro Study.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all